Neil J. Shah, MBBS

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Learn more about the insurance plans that participate with MSK.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

Health plans can change at any time. Call the number on the back of your insurance card to see what your plan covers. Make sure it covers the MSK location where you’ll get care.

If you have questions about insurance, call us at 646-497-9176.

• Clinical Trials Investigated by Dr. Shah
• A Phase 1b Study of HC-7366 and Belzutifan in People With Advanced Kidney Cancer
• A Phase I Study of XL092 with Immunotherapy in People with Solid Tumors
• A Study of PF-08634404 Alone and In Combination With Other Anticancer Drugs in People With Renal Cell Carcinoma
• Clinical Trials Co-Investigated by Dr. Shah
• A Phase IB/II Study of Immunotherapy and Targeted Combination Therapies in Patients with Kidney Cancer

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Neil J. Shah discloses the following relationships and financial interests:

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2025 through disclosure submission in spring 2026). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures